The global clinical trials market size is calculated at USD 87.42 billion in 2025 and is forecasted to reach around USD 149.58 billion by 2034, accelerating at a CAGR of 6.10% from 2025 to 2034. The North America clinical trials market size surpassed USD 49.67 billion in 2024 and is expanding at a CAGR of 6.30% during the forecast period. The market sizing and forecasts are revenue-based (USD Million/Billion), with 2024 as the base year.
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
3.1. Market Snapshot
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
5.1. COVID-19 Landscape: Clinical Trials Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
8.1. Clinical Trials Market, by Study Design
8.1.1 Interventional
8.1.1.1. Market Revenue and Forecast
8.1.2. Observational
8.1.2.1. Market Revenue and Forecast
8.1.3. Expanded Access
8.1.3.1. Market Revenue and Forecast
9.1. Clinical Trials Market, by Indication
9.1.1. Autoimmune/Inflammation
9.1.1.1. Market Revenue and Forecast
9.1.2. Pain Management
9.1.2.1. Market Revenue and Forecast
9.1.3. Oncology
9.1.3.1. Market Revenue and Forecast
9.1.4. CNS Condition
9.1.4.1. Market Revenue and Forecast
9.1.5. Diabetes
9.1.5.1. Market Revenue and Forecast
9.1.6. Obesity
9.1.6.1. Market Revenue and Forecast
9.1.7. Cardiovascular
9.1.7.1. Market Revenue and Forecast
9.1.8. Others
9.1.8.1. Market Revenue and Forecast
10.1. Clinical Trials Market, by Service Type
10.1.1. Laboratory Services
10.1.1.1. Market Revenue and Forecast
10.1.2. Bioanalytical Testing Services
10.1.2.1. Market Revenue and Forecast
10.1.3. Decentralized Clinical Trial Services
10.1.3.1. Market Revenue and Forecast
10.1.4. Patient Recruitment
10.1.4.1. Market Revenue and Forecast
10.1.5. Site Identification
10.1.5.1. Market Revenue and Forecast
10.1.6. Analytical Testing Services
10.1.6.1. Market Revenue and Forecast
10.1.7. Clinical Trial Supply & Logistic Services
10.1.7.1. Market Revenue and Forecast
10.1.8. Other Services
10.1.8.1. Market Revenue and Forecast
11.1. North America
11.1.1. Market Revenue and Forecast, by Study Design
11.1.2. Market Revenue and Forecast, by Indication
11.1.3. Market Revenue and Forecast, by Service Type
11.1.4. U.S.
11.1.4.1. Market Revenue and Forecast, by Study Design
11.1.4.2. Market Revenue and Forecast, by Indication
11.1.4.3. Market Revenue and Forecast, by Service Type
11.1.5. Rest of North America
11.1.5.1. Market Revenue and Forecast, by Study Design
11.1.5.2. Market Revenue and Forecast, by Indication
11.1.5.3. Market Revenue and Forecast, by Service Type
11.2. Europe
11.2.1. Market Revenue and Forecast, by Study Design
11.2.2. Market Revenue and Forecast, by Indication
11.2.3. Market Revenue and Forecast, by Service Type
11.2.4. UK
11.2.4.1. Market Revenue and Forecast, by Study Design
11.2.4.2. Market Revenue and Forecast, by Indication
11.2.4.3. Market Revenue and Forecast, by Service Type
11.2.5. Germany
11.2.5.1. Market Revenue and Forecast, by Study Design
11.2.5.2. Market Revenue and Forecast, by Indication
11.2.5.3. Market Revenue and Forecast, by Service Type
11.2.6. France
11.2.6.1. Market Revenue and Forecast, by Study Design
11.2.6.2. Market Revenue and Forecast, by Indication
11.2.6.3. Market Revenue and Forecast, by Service Type
11.2.7. Rest of Europe
11.2.7.1. Market Revenue and Forecast, by Study Design
11.2.7.2. Market Revenue and Forecast, by Indication
11.2.7.3. Market Revenue and Forecast, by Service Type
11.3. APAC
11.3.1. Market Revenue and Forecast, by Study Design
11.3.2. Market Revenue and Forecast, by Indication
11.3.3. Market Revenue and Forecast, by Service Type
11.3.4. India
11.3.4.1. Market Revenue and Forecast, by Study Design
11.3.4.2. Market Revenue and Forecast, by Indication
11.3.4.3. Market Revenue and Forecast, by Service Type
11.3.5. China
11.3.5.1. Market Revenue and Forecast, by Study Design
11.3.5.2. Market Revenue and Forecast, by Indication
11.3.5.3. Market Revenue and Forecast, by Service Type
11.3.6. Japan
11.3.6.1. Market Revenue and Forecast, by Study Design
11.3.6.2. Market Revenue and Forecast, by Indication
11.3.6.3. Market Revenue and Forecast, by Service Type
11.3.7. Rest of APAC
11.3.7.1. Market Revenue and Forecast, by Study Design
11.3.7.2. Market Revenue and Forecast, by Indication
11.3.7.3. Market Revenue and Forecast, by Service Type
11.4. MEA
11.4.1. Market Revenue and Forecast, by Study Design
11.4.2. Market Revenue and Forecast, by Indication
11.4.3. Market Revenue and Forecast, by Service Type
11.4.4. GCC
11.4.4.1. Market Revenue and Forecast, by Study Design
11.4.4.2. Market Revenue and Forecast, by Indication
11.4.4.3. Market Revenue and Forecast, by Service Type
11.4.5. North Africa
11.4.5.1. Market Revenue and Forecast, by Study Design
11.4.5.2. Market Revenue and Forecast, by Indication
11.4.5.3. Market Revenue and Forecast, by Service Type
11.4.6. South Africa
11.4.6.1. Market Revenue and Forecast, by Study Design
11.4.6.2. Market Revenue and Forecast, by Indication
11.4.6.3. Market Revenue and Forecast, by Service Type
11.4.7. Rest of MEA
11.4.7.1. Market Revenue and Forecast, by Study Design
11.4.7.2. Market Revenue and Forecast, by Indication
11.4.7.3. Market Revenue and Forecast, by Service Type
11.5. Latin America
11.5.1. Market Revenue and Forecast, by Study Design
11.5.2. Market Revenue and Forecast, by Indication
11.5.3. Market Revenue and Forecast, by Service Type
11.5.4. Brazil
11.5.4.1. Market Revenue and Forecast, by Study Design
11.5.4.2. Market Revenue and Forecast, by Indication
11.5.4.3. Market Revenue and Forecast, by Service Type
11.5.5. Rest of LATAM
11.5.5.1. Market Revenue and Forecast, by Study Design
11.5.5.2. Market Revenue and Forecast, by Indication
11.5.5.3. Market Revenue and Forecast, by Service Type
12.1. Parexel
12.1.1. Company Overview
12.1.2. Product Offerings
12.1.3. Financial Performance
12.1.4. Recent Initiatives
12.2. IQVIA
12.2.1. Company Overview
12.2.2. Product Offerings
12.2.3. Financial Performance
12.2.4. Recent Initiatives
12.3. Charles River Laboratory
12.3.1. Company Overview
12.3.2. Product Offerings
12.3.3. Financial Performance
12.3.4. Recent Initiatives
12.4. Omnicare
12.4.1. Company Overview
12.4.2. Product Offerings
12.4.3. Financial Performance
12.4.4. Recent Initiatives
12.5. Kendle
12.5.1. Company Overview
12.5.2. Product Offerings
12.5.3. Financial Performance
12.5.4. Recent Initiatives
12.6. Chiltern
12.6.1. Company Overview
12.6.2. Product Offerings
12.6.3. Financial Performance
12.6.4. Recent Initiatives
12.7. Pharmaceutical Product Development, LLC
12.7.1. Company Overview
12.7.2. Product Offerings
12.7.3. Financial Performance
12.7.4. Recent Initiatives
13.1. Primary Research
13.2. Secondary Research
13.3. Assumptions
14.1. About Us
14.2. Glossary of Terms
For questions or customization requests, please reach out to us at sales@precedenceresearch.com
Plan your call and get expert insights!
Schedule a Meeting
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client
Get a Sample
Report Description
Get a Sample
Report Description